REHOVOT, Israel, April 07, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced an amendment to the GLASSIA® ...
(RTTNews) - Israeli biopharmaceutical company Kamada Ltd. (KMDA) announced Wednesday an amendment to the GLASSIA [Alpha1-Proteinase Inhibitor (Human)] license agreement with Japanese peer Takeda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results